ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $718 | -28.2% | 6,191 | -2.1% | 0.00% | – |
| Q4 2022 | $1,000 | -50.0% | 6,327 | -37.9% | 0.00% | – |
| Q3 2022 | $2,000 | -60.0% | 10,191 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 10,191 | -19.7% | 0.00% | – |
| Q1 2022 | $7,000 | -12.5% | 12,691 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | -27.3% | 12,691 | +8.7% | 0.00% | – |
| Q3 2021 | $11,000 | +10.0% | 11,671 | +27.3% | 0.00% | – |
| Q2 2021 | $10,000 | +100.0% | 9,171 | +77.4% | 0.00% | – |
| Q1 2021 | $5,000 | -28.6% | 5,171 | -63.5% | 0.00% | – |
| Q4 2020 | $7,000 | +75.0% | 14,171 | +168.8% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 5,271 | -35.5% | 0.00% | – |
| Q2 2020 | $4,000 | +33.3% | 8,171 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 8,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |